Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah M Miller

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosisRuth Ann Marrie, Gordon J Chelune, Deborah M Miller, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|November 6, 2014
Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of lifeSalim Chahin, Laura J Balcer, Deborah M Miller, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 19, 2017
Idio Scale Judgment: evaluation of a new method for estimating responder thresholdsKaron F Cook, Michael A Kallen, Cheryl D Coon, et al.
Journal of the Neurological Sciences|February 8, 2005
Association of fatigue and brain atrophy in multiple sclerosisRuth Ann Marrie, Elizabeth Fisher, Deborah M Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2023
Long-term trajectories of ambulatory impairment in multiple sclerosisDouglas D Gunzler, Alessandro S De Nadai, Deborah M Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Mobility trajectories in multiple sclerosis: A comparative study of timed 25-foot walk and a patient-reported outcome measureFarren Bs Briggs, Douglas D Gunzler, Deborah M Miller, et al.
Complementary Therapies in Medicine|August 8, 2022
Components of a successful community-based exercise program for individuals with Parkinson's disease: Results from a participant surveyAnson B Rosenfeldt, Mandy Miller Koop, Amanda L Penko, et al.
Neurodegenerative Disease Management|April 16, 2024
Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumabCarrie M Hersh, Menglan Pang, Deborah M Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2026
Relationships between neighborhood deprivation, race, and worsening outcomes among MS patients 55 years of age and olderDeborah M Miller, Yadi Li, Scott Husak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2024
Multiple sclerosis subgroups: Data-driven clusters based on patient-reported outcomes and a large clinical sampleAlessandro S De Nadai, Ryan J Zamora, Alyse Finch, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosisRuth Ann Marrie, Gordon J Chelune, Deborah M Miller, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|November 6, 2014
Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of lifeSalim Chahin, Laura J Balcer, Deborah M Miller, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 19, 2017
Idio Scale Judgment: evaluation of a new method for estimating responder thresholdsKaron F Cook, Michael A Kallen, Cheryl D Coon, et al.
Journal of the Neurological Sciences|February 8, 2005
Association of fatigue and brain atrophy in multiple sclerosisRuth Ann Marrie, Elizabeth Fisher, Deborah M Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2023
Long-term trajectories of ambulatory impairment in multiple sclerosisDouglas D Gunzler, Alessandro S De Nadai, Deborah M Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Mobility trajectories in multiple sclerosis: A comparative study of timed 25-foot walk and a patient-reported outcome measureFarren Bs Briggs, Douglas D Gunzler, Deborah M Miller, et al.
Complementary Therapies in Medicine|August 8, 2022
Components of a successful community-based exercise program for individuals with Parkinson's disease: Results from a participant surveyAnson B Rosenfeldt, Mandy Miller Koop, Amanda L Penko, et al.
Neurodegenerative Disease Management|April 16, 2024
Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumabCarrie M Hersh, Menglan Pang, Deborah M Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2026
Relationships between neighborhood deprivation, race, and worsening outcomes among MS patients 55 years of age and olderDeborah M Miller, Yadi Li, Scott Husak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2024
Multiple sclerosis subgroups: Data-driven clusters based on patient-reported outcomes and a large clinical sampleAlessandro S De Nadai, Ryan J Zamora, Alyse Finch, et al.
Pageof 5